Clàudia Fortuny Guasch
Investigador
Research group
Professional network profiles
Last Publications
- Epalza, C, Valadés-Alcaraz, A, González-Alba, JM, Beltrán-Pavez, C, Gutiérrez-López, M, Rubio-Garrido, M, Fortuny-Guasch C, Frick, MA, Medina, LM, Moreno, S, Sanz, J, Rojo, P, Navarro, ML and Holguín, A Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain PEDIATRIC INFECTIOUS DISEASE JOURNAL . 43(1): 40-48.
- Soler-García a, Gamell Fullà A, Manuel Monsonis Cabedo, Korta-Murua JJ, Espiau M, Rincón-López E, Rodríguez-Molino P, Pérez-Porcuna T, Bustillo-Alonso M, Santiago B, Tebruegge M and Noguera-Julián A The Value of the Second QuantiFERON-TB Gold-Plus Antigen Tube at Diagnosis and at Treatment Completion in Spanish Children With Tuberculosis. PEDIATRIC INFECTIOUS DISEASE JOURNAL . 42(11): 1017-1020.
- Armangue-Salvador T, Olivé-Cirera G, Martínez-Hernandez E, Rodes M, Peris-Sempere V, Guasp M, Ruiz R, Palou E, González A, Marcos MÁ, Erro ME, Bataller L, Corral-Corral Í, Planagumà J, Caballero E, Vlagea A, Chen J, Bastard P, Materna M, Marchal A, Abel L, Cobat A, Alsina L, Fortuny-Guasch C, Saiz A, Mignot E, Vanderver A, Casanova JL, Zhang SY and Dalmau J Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies. BRAIN . 146(10): 4306-4319.
Projects
- Project name:
- SGR 2022-2024_Enfermedades Infecciosas en la Edad Pediátrica y Microbioma
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 00396
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Science4Pandemics: Cizitens engagement digital platform for collective intelligence in pandemics
- Leader
- Begoña Nafria Escalera
- Funding entities:
- Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD, EIT Health e.V
- Code
- 220365
- Starting - finishing date:
- 2022 - 2024
- Project name:
- Estudio de la toxicidad mitocondrial en recien nacidos y lactantes con infección congénita por citomegalovirus tratados con ganciclovir o valganciclovir
- Leader
- Clàudia Fortuny Guasch
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI17/00359
- Starting - finishing date:
- 2018 - 2022
News
-
Measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections
A study, published in BMC Medicine, performed through the Kids Corona platform from Sant Joan de Déu in collaboration with ISGlobal, shows that measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections.